Builders have too many new homes on their hands. But before they slash prices, they have another option: sell to investors in ...
The clinical-stage biopharmaceutical company named Julie Eastland as chief executive officer, president and director. She succeeds Kimberly Blackwell, who will remain as a strategic advisor to the ...